Interim Results of a Multicenter Trial with the New Electronic Subretinal Implant Alpha AMS in 15 Patients Blind from Inherited Retinal Degenerations

Interim Results of a Multicenter Trial with the New Electronic Subretinal Implant Alpha AMS in 15 Patients Blind from Inherited Retinal Degenerations

Purpose: We assessed the safety and efficacy of a technically advanced subretinal electronic implant, RETINA IMPLANT Alpha AMS, in end stage retinal degeneration in an interim analysis of two ongoing prospective clinical trials. The purpose of this article is to describe the interim functional resul...

Full description

Bibliographic Details
Main Authors: Katarina Stingl, Ruth Schippert, Karl U. Bartz-Schmidt, Dorothea Besch, Charles L. Cottriall, Thomas L. Edwards, Florian Gekeler, Udo Greppmaier, Katja Kiel, Assen Koitschev, Laura Kühlewein, Robert E. MacLaren, James D. Ramsden, Johann Roider, Albrecht Rothermel, Helmut Sachs, Greta S. Schröder, Jan Tode, Nicole Troelenberg, Eberhart Zrenner
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-08-01
Series:Frontiers in Neuroscience
Subjects:
subretinal implant
RETINA IMPLANT Alpha AMS
neuroprosthetics
retinitis pigmentosa
artificial vision
hereditary retinal disease
Online Access:http://journal.frontiersin.org/article/10.3389/fnins.2017.00445/full

Internet

http://journal.frontiersin.org/article/10.3389/fnins.2017.00445/full

Similar Items